Results 1 to 10 of about 395,223 (154)
Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences
Pharmaceuticals, 2021 Atypical antipsychotics (AAPs) are commonly prescribed medications to treat schizophrenia, bipolar disorders and other psychotic disorders. However, they might cause metabolic syndrome (MetS) in terms of weight gain, dyslipidemia, type 2 diabetes (T2D ...
Marco Scarselli +2 more
exaly +2 more sources
Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents
Pharmaceuticals, 2020 This is a comprehensive review of the literature on drug interactions (DIs) between atypical antipsychotics and anti-infective agents that focuses on those DIs with the potential to be clinically relevant and classifies them as pharmacokinetic (PK) or ...
Edoardo Spina +3 more
doaj +2 more sources
International Journal of Molecular Sciences, 2017 Atypical antipsychotics (AAP) are the prevailing form of schizophrenia treatment today due to their low side effects and superior efficacy. Nevertheless, some issues still need to be addressed.
Yong-Ku Kim +2 more
exaly +2 more sources
Atypical antipsychotics in the treatment of delirium [PDF]
Psychiatry and Clinical Neurosciences, 2013 The aim of this study was to review the efficacy and safety of atypical antipsychotics, comparing within class, placebo, or compared to another active treatment for delirium. A literature search was conducted using PubMed, EMBASE, and the Cochrane database (1 January 1990–5 November 2012).
H. Wang, Y. Woo, W. Bahk
semanticscholar +3 more sources
Revista Gestão & Saúde, 2015 The aim was to identify adverse events arising from the continued use of atypical antipsychotics through cohort and case control studies, carried out on a worldwide level, in the period from 2013 and 2014.
Claudia Aparecida Avelar Ferreira +4 more
doaj +1 more source
The Effect of Atypical Anti-psychotic Agents on Obesity and Glucose Metabolism [PDF]
Journal of Medicine and Life Science, 2021 Atypical antipsychotics are more effective than typical antipsychotics and have fewer side effects such as tardive dyskinesia and extrapyramidal symptoms; therefore, prescriptions of atypical antipsychotics are increasing.
Sang Ah Lee, Suk Ju Cho, Jae Cheol Moon
doaj +1 more source
New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
International Journal of Molecular Sciences, 2022 Schizophrenia and depression are heterogeneous disorders. The complex pathomechanism of the diseases imply that medication responses vary across patients.
Jolanta Orzelska-Górka +3 more
semanticscholar +1 more source
Asenapine: an atypical antipsychotic with atypical formulations [PDF]
Therapeutic Advances in Psychopharmacology, 2021 Asenapine is a second-generation (atypical) antipsychotic medication not available in a pill that can be swallowed; rather, it is commercialized in sublingual and transdermal formulations. This is a consequence of extensive first-pass metabolism if ingested. The sublingual formulation is approved in many jurisdictions for the treatment of schizophrenia
Meghan Musselman +2 more
openaire +3 more sources
Atypical Antipsychotics and Parkinsonism [PDF]
Archives of Internal Medicine, 2005 Atypical antipsychotic agents are thought to be less likely than older typical agents to produce parkinsonism. This has not been well documented. We compared the risk of development of incident parkinsonism among older adults dispensed atypical relative to typical antipsychotics.Retrospective cohort study of all adults 66 years and older in Ontario. We
Rochon, Paula A. +12 more
openaire +3 more sources
Atypical Antipsychotics Induced Metabolic Syndrome [PDF]
Psikiyatride Güncel Yaklaşımlar, 2015 The use of atypical antipsychotics in patients with schizophrenia is tightly related to the metabolic abnormalities like weight gain, diabetes, dyslipidemia and/or hypertension.
Aysegul Demirel +2 more
doaj +1 more source